Document is current
Any future updates will be listed below
-
Authors
Pinto Salgueiro, Gonçalo
Yilmaz, Orhan
Nogueira, Miguel
Torres, Tiago https://orcid.org/0000-0003-0404-0870
-
Funding
Funding for this research was provided by:
Universidade do Porto
- License Information
-
More Information
Article History
Accepted: 24 October 2024
First Online: 28 November 2024
Declarations
:
: No sources of funding were used to conduct this study or prepare this article.
: Orhan Yilmaz has no conflicts of interest. Gonçalo Pinto Salgueiro has no conflicts of interest. Miguel Nogueira has received consultancy and/or speaker’s honoraria from AbbVie and LEO Pharma. Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Janssen, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz, and UCB.
: Not applicable.
: Not applicable.
: Data availability is not applicable to this article as no new data were created or analyzed in this study. This is a narrative review, and all sources of information are cited appropriately in the article.
: Not applicable.
: All the authors contributed equally to the preparation of this review. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
